Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
Autor: | Stephen D. Silberstein, Virginia L. Stauffer, Katie A. Day, Sarah Lipsius, Maria-Carmen Wilson |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-2 (2019) |
Druh dokumentu: | article |
ISSN: | 1129-2369 1129-2377 |
DOI: | 10.1186/s10194-019-1069-x |
Popis: | After publication of our article [1] we were notified that the data presented in the upper row of Fig. 7 was inadvertently the least square mean change from baseline (standard error) at Month 6 rather than the overall average of Month 3 and Month 6. The figure legend and discussion of the data in the text were and are correct. The error was only in the upper row of Fig. 7. The legend for Fig. 7 did not require revision. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |